Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

to determine whether digoxin is effective in converting atrial fibrillation of recent onset to normal sinus rhythm. randomized, double-blinded, placebo-controlled trial with a maximum 18-hour treatment period. emergency room and medical floors of a non-referral city hospital. consecutive sample of 3...

Full description

Saved in:

Bibliographic Details
Published in:	Annals of internal medicine Vol. 106; no. 4; p. 503
Main Authors:	Falk, R H, Knowlton, A A, Bernard, S A, Gotlieb, N E, Battinelli, N J
Format:	Journal Article
Language:	English
Published:	United States 01-04-1987
Subjects:	Atrial Fibrillation - drug therapy Atrial Fibrillation - physiopathology Clinical Trials as Topic Digoxin - blood Digoxin - therapeutic use Double-Blind Method Heart Rate - drug effects Humans Middle Aged Myocardial Contraction - drug effects Random Allocation Stroke Volume - drug effects
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	to determine whether digoxin is effective in converting atrial fibrillation of recent onset to normal sinus rhythm. randomized, double-blinded, placebo-controlled trial with a maximum 18-hour treatment period. emergency room and medical floors of a non-referral city hospital. consecutive sample of 36 patients with atrial fibrillation of 7 days' duration or less, not on digitalis glycoside or anti-arrhythmic agents, with ventricular rate between 85 to 175 beats/min, without evidence of heart failure, acute myocardial infarction, unstable angina, preexcitation syndrome, thyrotoxicosis, hypokalemia, renal impairment, or severe metabolic disturbances. digoxin solution in capsules or identical placebo, given in doses of 0.6, 0.4, 0.2, and 0.2 mg, at 0, 4, 8, and 14 hours, respectively, or until conversion to sinus rhythm, whichever occurred first. Continuous electrocardiographic recording by Holter monitor. nine of eighteen patients receiving digoxin and 8 of 18 receiving placebo had a return to sinus rhythm within 18 hours of study entry (95% confidence interval for the difference in proportions, -11% to 22%). Mean time to conversion was 5.1 hours in the digoxin group and 3.3 in the placebo group (95% Cl, -3.6 to 7.0 hours). spontaneous reversion to sinus rhythm is common in patients with atrial fibrillation of recent onset. Digitalization was not shown to affect the likelihood of reversion to sinus rhythm, and thus cannot be recommended for this purpose in patients with atrial fibrillation.
ISSN:	0003-4819
DOI:	10.7326/0003-4819-106-4-503